PMID- 21306641 OWN - NLM STAT- MEDLINE DCOM- 20120301 LR - 20211020 IS - 1749-799X (Electronic) IS - 1749-799X (Linking) VI - 6 DP - 2011 Feb 9 TI - The role of FGF-2 and BMP-2 in regulation of gene induction, cell proliferation and mineralization. PG - 8 LID - 10.1186/1749-799X-6-8 [doi] AB - INTRODUCTION: The difficulty in re-growing and mineralizing new bone after severe fracture can result in loss of ambulation or limb. Here we describe the sequential roles of FGF-2 in inducing gene expression, cell growth and BMP-2 in gene expression and mineralization of bone. MATERIALS AND METHODS: The regulation of gene expression was determined using real-time RTPCR (qRTPCR) and cell proliferation was measured by thymidine incorporation or fluorescent analysis of DNA content in MC3T3E1 osteoblast-like cells. Photomicroscopy was used to identify newly mineralized tissue and fluorescence was used to quantify mineralization. RESULTS: Fibroblast growth factor-2 (FGF-2) had the greatest ability to induce proliferation after 24 hours of treatment when compared to transforming growth factor beta (TGFbeta, insulin-like growth factor-1 (IGF-1), bone morphogenic protein (BMP-2), platelet derived growth factor (PDGF) or prostaglandin E(2) (PGE(2)). We found that FGF-2 caused the most significant induction of expression of early growth response-1 (egr-1), fgf-2, cyclo-oxygenase-2 (cox-2), tgfbeta and matrix metalloproteinase-3 (mmp-3) associated with proliferation and expression of angiogenic genes like vascular endothelial growth factor A (vegfA) and its receptor vegfr1. We found that FGF-2 significantly reduced gene expression associated with mineralization, e.g. collagen type-1 (col1a1), fibronectin (fn), osteocalcin (oc), IGF-1, noggin, bone morphogenic protein (bmp-2) and alkaline phosphatase (alp). In contrast, BMP-2 significantly stimulated expression of the mineralization associated genes but had little or no effect on gene expression associated with growth. CONCLUSIONS: The ability of FGF-2 to re-program a mineralizing gene expression profile to one of proliferation suggests that FGF-2 plays a critical role of osteoblast growth in early fracture repair while BMP-2 is instrumental in stimulating mineralization. FAU - Hughes-Fulford, Millie AU - Hughes-Fulford M AD - Department of Research, Veterans Affairs Medical Center, 4150 Clement Street, San Francisco, CA 94121, USA. millie.hughes-fulford@ucsf.edu FAU - Li, Chai-Fei AU - Li CF LA - eng PT - Journal Article PT - Research Support, U.S. Gov't, Non-P.H.S. DEP - 20110209 PL - England TA - J Orthop Surg Res JT - Journal of orthopaedic surgery and research JID - 101265112 RN - 0 (Bmp2 protein, mouse) RN - 0 (Bone Morphogenetic Protein 2) RN - 0 (Platelet-Derived Growth Factor) RN - 0 (Transforming Growth Factor beta) RN - 103107-01-3 (Fibroblast Growth Factor 2) RN - 67763-96-6 (Insulin-Like Growth Factor I) RN - K7Q1JQR04M (Dinoprostone) SB - IM MH - Animals MH - Bone Morphogenetic Protein 2/genetics/pharmacology/*physiology MH - Calcification, Physiologic/drug effects/*physiology MH - Cell Differentiation/drug effects/physiology MH - Cell Line MH - *Cell Proliferation/drug effects MH - Dinoprostone/pharmacology MH - Fibroblast Growth Factor 2/genetics/pharmacology/*physiology MH - Gene Expression Regulation/drug effects/*physiology MH - In Vitro Techniques MH - Insulin-Like Growth Factor I/pharmacology MH - Mice MH - Osteoblasts/*cytology/drug effects/*physiology MH - Platelet-Derived Growth Factor/pharmacology MH - Time Factors MH - Transforming Growth Factor beta/pharmacology PMC - PMC3044105 EDAT- 2011/02/11 06:00 MHDA- 2012/03/02 06:00 PMCR- 2011/02/09 CRDT- 2011/02/11 06:00 PHST- 2010/07/29 00:00 [received] PHST- 2011/02/09 00:00 [accepted] PHST- 2011/02/11 06:00 [entrez] PHST- 2011/02/11 06:00 [pubmed] PHST- 2012/03/02 06:00 [medline] PHST- 2011/02/09 00:00 [pmc-release] AID - 1749-799X-6-8 [pii] AID - 10.1186/1749-799X-6-8 [doi] PST - epublish SO - J Orthop Surg Res. 2011 Feb 9;6:8. doi: 10.1186/1749-799X-6-8.